EGF and cancer: Apart from FGFR signaling, syndecan-4 also affects epidermal growth factor (EGF)-mediated signaling, albeit through a different mechanism: It has been shown that EGF-dependent cancer cell migration is mediated through a complex of human epidermal growth factor receptor-1 (EGFR), α6β4 integrin and Sdc4.